← Open Payments lookup

GIOVANNA PRIVITERA: Open Payments

NPI 1174284459 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,586 in 229 payments from 22 companies in 2025. Trend: 2023 $3,066 · 2024 $3,264 · 2025 $4,586

Food & beverage: $4,576Education: $10
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.28$609
Vanda Pharmaceuticals Inc.29$537
Janssen Pharmaceuticals, Inc17$531
Alkermes, Inc.23$509
ABBVIE INC.28$449
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$430
Takeda Pharmaceuticals U.S.A., Inc.15$247
Axsome Therapeutics, Inc.9$192
Bausch Health US, LLC9$188
Neurocrine BioSciences, Inc.13$187

Products named: REXULTI, FANAPT, SPRAVATO, VRAYLAR, CAPLYTA, LYBALVI, TRINTELLIX, ARISTADA.

Industry payments across TX — which companies pay providers there.